Jeff Yass’s enVVeno Medical NVNO Stock Holding History

Jeff Yass’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,377	Closed	-$500K	–	13666
2021 Q3	$500K	Buy	+1,377	New	+$357K	﹤0.01%	9403

Other funds holding NVNO

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jeff Yass's NVNO Position: Q1 2026 in Review

Jeff Yass sold out of enVVeno Medical (NVNO) in Q1 2026, closing a stake of 3,781 shares — an estimated $42.5K sold.

Jeff Yass first reported a position in NVNO in Q3 2018 and held it in 11 quarters. The position peaked at $318K in Q3 2023. 17 funds tracked by Wall St. Rank hold NVNO as of Q1 2026.

Jeff Yass reported no remaining enVVeno Medical position as of Q1 2026 after selling out during the quarter.
Jeff Yass sold 3,781 enVVeno Medical shares in Q1 2026, an estimated $42.5K.
Jeff Yass first reported a position in enVVeno Medical in Q3 2018 and held it in 11 quarters.
Jeff Yass's enVVeno Medical position peaked at $318K in Q3 2023.
17 funds tracked by Wall St. Rank held enVVeno Medical as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.